Strategic Buy Camargo is a mid-sized global drug development partner with a focus on complex programs and accelerated pathways, presenting opportunities to sell expanded development services, regulatory consulting, and strategy support to sponsors seeking speed and capital efficiency.

M&A Access Recent acquisition by Premier Research and past acquisitions indicate a growth trajectory and broader capabilities, suggesting sales opportunities to cross-sell integrated services, portfolio optimization, and access to a larger corporate client base through Premier Research channels.

Global Reach With clients in over 35 countries, Camargo demonstrates geographic diversification and exposure to diverse regulatory environments, offering upsell opportunities in global regulatory strategy, submission support, and market access services.

Therapy Expertise Specialization in rare diseases, orphan drugs, 505(b)(2), oncology, neurology, pediatrics, and digital therapeutics positions Camargo to target sponsors pursuing niche development programs with high regulatory complexity and accelerated pathways.

Growth Enablement Past hires of senior strategy and commercial executives and ongoing expansion through acquisitions signal a readiness to scale; sales can focus on end-to-end development-to-commercial solutions and consulting packages that align with sponsors’ milestone-driven funding.